Remove Development Remove Doctors Remove Pharmacy
article thumbnail

UCB taps Medisafe in development of digital companion to support patient engagement

Pharma Mirror

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its antiepileptic medications, with greater capabilities to expand across additional brands. 1 in 26 people in the US will develop epilepsy at some point in their.

article thumbnail

Does CVS have a crystal ball into the future?

World of DTC Marketing

In the words of the company’s mission , its goal is to “make high-quality health and pharmacy services safe, affordable and easy to access.” You can find anything on Amazon, but soon you will be able to “see” a nurse, a doctor, or get a diagnosis using telehealth within minutes, from the comfort of your home.

Pharmacy 241
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FTC launches probe into pharmacy benefit management sector

pharmaphorum

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). The post FTC launches probe into pharmacy benefit management sector appeared first on.

article thumbnail

Digital health: the new normal?

pharmaphorum

Whether catching up with relatives, attending a business meeting, or even visiting a doctor, it became commonplace to conduct this type of activity via a screen. According a Pew Research study, 81% of participants said they have used video calls to talk to others since the onset of the pandemic. Tapping into data.

Genetics 145
article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

Drug development and working with specialised Rare Disease networks

pharmaphorum

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals. The potential to leverage genomic data.